Médecins Sans Frontières, also known as Doctors Without Borders, has warned that shortages of diphtheria antitoxin are putting thousands of children at risk of severe illness and death in Nigeria.
The organisation raised the concern in a statement published on its website, warning that inadequate supplies of the life-saving drug and low immunisation coverage are worsening the outbreak, particularly in northern Nigeria.
MSF’s Medical Coordinator in Nigeria, Dr David Kizito, said the organisation’s stocks were dangerously low, raising concerns that medical teams might be unable to treat patients as cases continue to emerge.
He explained that diphtheria antitoxin is the only specific treatment that neutralises the toxin produced by the disease and is most effective when administered within 48 hours of the onset of symptoms.
Daily Source also observed that, according to MSF’s figures, Nigeria has recorded more than 41,000 suspected cases, over 24,000 confirmed infections and more than 1,260 deaths since the outbreak began in late 2022.
As of August 9, 2026, the country had recorded 12,977 suspected cases, 10,476 confirmed infections and 406 deaths in the year alone.
MSF said it had treated more than 9,000 diphtheria patients in 2026 and supported vaccination campaigns in Kano and Sokoto states.
The organisation called on federal and state governments, donors and international partners to urgently secure supplies of antitoxin, vaccines and other essential medicines, while improving distribution to affected communities.
It also urged manufacturers and global health partners to expand antitoxin production and ensure a reliable supply to Nigeria and other countries facing rising infections.